Carlyle in talks to buy Baxter’s kidney care unit, source says By Reuters
(Reuters) - Private equity firm The Carlyle Group Baxter International Inc (NYSE:BAX) is in exclusive talks to buy kidney care company Vantiv for more than $4 billion, including debt, a person familiar with the matter told Reuters…